Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) FCF Margin: 2020-2024

Historic FCF Margin for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -42.98%.

  • Journey Medical's FCF Margin fell 561.00% to -13.52% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.62%, marking a year-over-year increase of 4163.00%. This contributed to the annual value of -42.98% for FY2024, which is 4328.00% down from last year.
  • As of FY2024, Journey Medical's FCF Margin stood at -42.98%, which was down 14,280.35% from 0.30% recorded in FY2023.
  • In the past 5 years, Journey Medical's FCF Margin ranged from a high of 0.30% in FY2023 and a low of -45.52% during FY2022.
  • Over the past 3 years, Journey Medical's median FCF Margin value was -42.98% (recorded in 2024), while the average stood at -29.40%.
  • As far as peak fluctuations go, Journey Medical's FCF Margin spiked by 4,582bps in 2023, and later tumbled by 4,328bps in 2024.
  • Over the past 5 years, Journey Medical's FCF Margin (Yearly) stood at -6.15% in 2020, then skyrocketed by 270bps to -3.45% in 2021, then crashed by 4,207bps to -45.52% in 2022, then surged by 4,582bps to 0.30% in 2023, then plummeted by 4,328bps to -42.98% in 2024.